Ozempic and Wegovy (and Rybelsus, which is oral semaglutide) are GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s) and are the only FDA-approved drugs that contain the active ingredient semaglutide
Key Facts Research compound used in metabolic studies Not approved for cosmetic application Works on appetite regulation pathways in clinical settings In skincare discussions, it is sometimes incorrectly grouped with peptide serums, but this is scientifically inaccurate
Unlike BPC-157, TB-500, and GHK-Cu, which remain investigational, teriparatide (PTH 1-34) and abaloparatide have received FDA approval for treating osteoporosis and are prescribed to patients worldwide
See our L-Carnitine dosage reference for dose-by-goal guidance.
Goldstein, A.L., Hannappel, E
Separate vials let the TB-4 or TB-500 dose rise without multiplying the other three